Status:
COMPLETED
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Rochester General Hospital
Conditions:
Respiratory Infections
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This trial is a pilot study to determine the feasibility of a randomized clinical trial comparing a treatment algorithm consisting of a limited number of clinical parameters, rapid molecular viral dia...
Detailed Description
This is trial is a pilot study to determine the feasibility of a randomized clinical trial comparing a treatment algorithm consisting of a limited number of clinical parameters, rapid molecular viral ...
Eligibility Criteria
Inclusion
- Hospitalized with symptoms of a respiratory infection
- Age \> 21 years
- Systolic Blood Pressure \> 90mm Hg
- Patient or health care designee can provide written informed consent
Exclusion
- Intensive Care Requirement
- Antibiotics received prior to admission
- More than 24 hours of antibiotics received prior to enrollment
- Active chemotherapy or pulmonary radiation therapy
- Immunosuppressive conditions
- Conditions know to increase PCT values
- Definite infiltrate on CXR •% of band forms in peripheral blood \> 15
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01907659
Start Date
October 1 2013
End Date
June 1 2014
Last Update
July 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rochester General Hospital
Rochester, New York, United States, 14621